Forbes
The UpStart Entrepreneurs Redefining the American Dream
POPS! Diabetes Care, Inc.
AI Powered Digital Healthcare
Minneapolis, MN
Health Tech
We have developed and commercialized a revolutionary AI self-care platform for diabetes management. Our mission is for people to take ownership of their diabetes through simple technology, and we have people in all 50 states and Australia using Pops.
$48,077
raised
$2,441,010
previously crowdfunded
41
Investors
$17.9M
Valuation
$7.43
Price per Share
$200.61
Min. Investment
Preferred
Shares Offered
Equity
Offering Type
$2.56M
Offering Max
0
Days Left
This offering ended on July 27, 2022 and is no longer accepting investments.
Reasons to Invest
Pops revenue grew 93% average quarter-over-quarter throughout 2021. The US diabetes device market is valued at $18.9B. We seek to empower the 37.3 million Americans with diabetes to manage their condition.*
We proudly have FDA Clearance, published clinical study outcomes, 100% client retention rate over three years, a Net Promoter Score of 75, and Pops users in Australia and all 50 states.
Pops has 15 issued and 7 pending patents, as well as a scalable software platform that is expanding into weight control, hypertension, and high cholesterol using the funds from this raise.
*Information and market statistics provided by Mordor Intelligence and the Center for Disease Control & Prevention (source / source)
Live Life on Your Terms
The inception for Pops came about while the co-founders were on a fishing trip in Minnesota. We noticed Lonny (CEO and co-founder) struggling to check and manage his blood sugar as his co-founder reeled in a large walleye, which begged the question: “Why can’t I easily manage my diabetes and blood sugar while I am doing what I love?”
Immediately hooked on the idea, we created a simple, all-in-one glucose meter that connects wirelessly to the Pops app, enabling users to view trends at the touch of a button. Along with our virtual AI assistant, Mina, we are simplifying the ability to manage chronic conditions like diabetes.
The COVID-19 pandemic has boosted the awareness of self-care even more, with the global mobile health market currently valued at $56B and expected to grow at 30% CAGR through 2030 (source). Today, healthcare is happening at home, which is exactly why Pops strives to empower people living with diabetes to manage their condition - on their terms.
The Problem
Diabetes is Overwhelming and Exhausting to Manage
One of the most frustrating and difficult challenges of diabetes is its relentlessness. It demands thoughtful attention to detail, structure, and constant monitoring, and all of those tasks fall solely on the shoulders of the person who suffers from diabetes. This nonstop series of stressors can lead to burnout and severe emotional distress.
Even though we live in a digital age, self-care for diabetes is still in its primitive stages. There is a stunning lack of diabetes management tools that integrate easily into our lives which makes the individual’s decision to self-manage their symptoms all the more exhausting to make.
The Solution
Powered by AI, a Self-Care Platform Designed to Make Life Easier
Pops offers one of the most discreet, easy-to-use diabetes management systems available today. Our service revolves around a personalized, app-based AI virtual assistant, Mina, who will remind you to check your blood sugar as needed, encourage you to be more active, and even make recommendations to help you Own Your Life®. Using a practice known as motivational interviewing, Mina can assist with changing healthcare behaviors and making condition management easier.
Our platform broadens connectivity and data sharing with loved ones and providers, with an innovative, cost-saving solution for clients, individuals, and the healthcare ecosystem.
Mina pairs wirelessly with the Pops Rebel Meter - an easy-to-use, discreet, smart-glucose meter that transforms the traditional test kit into one seamless meter that connects to the phone that you carry with you every day. With our all-in-one system, you can check your blood sugar on the go, ensuring your diabetes never slows you down. Around 20% the size of traditional meters, the Rebel requires no assembly and is less painful.
While Continuous Glucose Monitors (CGM) are gaining popularity, they are used by less than 10% of people with diabetes after being on the market for more than ten years.* The Pops Rebel will be a relevant advantage for many years to come, and eventually Mina will evolve to incorporate CGM data.
*Information based on internal research using analyses such as this update from Dexcom (source)
The third part of the simple self-care platform is our ecosystem partner organizations, curated to eliminate the barriers of why someone will not manage their condition. With Mina at the center directing traffic, these partnerships were developed to make life simpler for a person with diabetes or another chronic condition. The Pops ecosystem includes a variety of partners and continues to grow.
Pops sells access to the platform as a subscription service, both direct-to-consumer and business-to-business through clients like Best Buy Health and Zurich Insurance Group.
For B2B, we are targeting the growing digital healthcare environment by selling to consumer health, alternative primary care, and tele-health organizations. For B2B, we are targeting the growing digital healthcare environment by selling to consumer health, alternative primary care, and tele-health organizations. These three target market categories have many companies to whom Pops can sell our consumer-focused digital health platform to complement their existing technology.
Our competitors (e.g. Livongo, Omada, and Onduo) are Remote Patient Monitoring (RPM) companies using live coaches. While they are indeed remotely managing patients, Pops is enabling people to take care of themselves. The clients we are targeting don’t want live coaching, they want digital solutions to manage their chronic conditions like diabetes.
Beyond diabetes, Pops has an established software platform that can scale to incorporate other chronic conditions that would benefit from our self-care ecosystem. We plan to use a portion of the funds from this raise to expand the platform into conditions related to diabetes including weight control, high blood pressure, and high cholesterol.
Sources: Hypertension / Diabetes / Hyperlipidemia / Obesity
THE TRACTION
Significant Sales and Clinically Proven to Improve Management of Diabetes
We are FDA-cleared, TGA-cleared, CE-marked, and in-use across all 50 states and in Australia. Pops is sold as a subscription service to clients and individuals, with a whopping 986% revenue growth from Q4 2021 through Q4 2020, and a 93% average quarter-over-quarter growth throughout 2021.
We have also secured agreements with multiple corporations including Best Buy, Zurich Insurance Group, and Medline where Pops will be offered as the diabetes solution in their healthcare offering.
Pops has been proven as a safe, accurate, and effective tool to manage diabetes. A recent peer-reviewed study in the International Journal of Digital Health showed people who used the Pops Self-care platform to manage their diabetes had a significant 1.3 point drop (17% improvement) in A1c, the clinical measure of blood sugar.
Currently, we have 15 issued patents with another 7 pending patents. Pops has also signed agreements with a variety of ecosystem partners to further simplify the lives of Pops users.
*These testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.
The market
Modern Healthcare Tools are Changing the Environment
The Center for Disease Control and Prevention estimates 37.3 million Americans, or about 1 in 10 people, have diabetes, 20% of which are believed to be unaware of their condition (source).
An additional 96 million Americans are estimated to have pre-diabetes, a less severe classification with equally important risk factors to monitor. (source)
In 2021, the US diabetes devices market was valued at $18 billion (source). Despite the market size, many living with diabetes find the management of their blood sugar to be cumbersome with the currently available solutions. Today’s test kits and diabetes services do not fit well with people’s active and fast-paced lives.
The market becomes even larger with the diabetes-related conditions of weight, hypertension, and hyperlipidemia that the Pops platform is expanding to address.
Pops is trailblazing this emerging field of at-home healthcare management and self-care tools. People don’t need to wait to be taken care of like a patient. With Mina and the Pops ecosystem, we are solving these daily challenges, providing meaningful education and guidance for people to manage their diabetes on-the-go.
Pops has reached more than 10,000 followers on social media and 10,000 visits per month to its website, evidence that there is consumer interest in self-care.
Why invest
Pops is Enabling People With Chronic Conditions to Own Their Lives
Pops was founded to put simple technology in people’s hands to enable them to Own Their Life®. Our revolutionary platform is clinically proven to improve the management of diabetes, and we seek to continue our mission, providing people the ability to live life on their terms.
Help us empower millions of people living with chronic conditions and join the ground floor of an industry-defining endeavor by investing in Pops today.
Replace
Drop image
(or click)
(or click)
In the Press
Entrepreneur
Pepperdine's Most Fundable Companies of 2018
Wall Street Journal Pro
POPS Diabetes Care Raises $1.2 Million for Blood-Glucose Testing
The Observer
2020 List of the Hottest "Flyover Tech" Companies in Digital Health
Diabetes Technology Society
March 2019, Journal of Diabetes Science and Technology
Coverager
Zurich Australia partners with Pops Diabetes Care
International Journal of Digital Health
Sustained Improvement of HbA1C in a Non-Randomized Trial Through Use of AI Virtual Health Assistant and Consumer Friendly Glucose Measurement for People with Diabetes
NewsBreak
Vous Vitamin and Pops combine forces for blood sugar management
Bloomberg
Pops AI Virtual Health Assistant and Glucometer Now Available at Best Buy
MobileHealthNews
Smartphone-connected glucometer Pops! Diabetes Care rakes in $6M
Mission Matters
Pops Diabetes Care Brings AI to Healthcare with Lonny Stormo
Insurance News AU
Zurich pilots diabetes self-management health app
The Business Journals
Health-Tech Startup POPS! Diabetes Care Closes on $6M
Mass Device
Pops Diabetes wins FDA clearance for blood glucose monitoring system
Medgadget
POPS! one System for Easy Blood Glucose Testing Cleared by FDA
Benzinga
POPS! Diabetes Care Announces FDA Clearance of Their POPS!® one System
Diabetes Self Management
Pops! Blood Glucose Monitoring System Gets FDA Approval
Digital Health Times
MedTech Innovator Announces 50 MedTech Startups Selected for Annual Showcase and Accelerator
MedCity News
TreeHouse Health — an innovation hub for healthcare startups
Medtech Innovation
MedTech Innovator announces 50 companies selected for accelerator
AP News
POPS! Diabetes Care Announces the Commercial Launch of their POPS!® one System
Nutritional Outlook
Vous Vitamin’s personalized nutrition partnership with diabetes coaching system Pops is a first, firm says
HealthTech Insider
Blood Sugar Testing Made Easy with a Smartphone
VC News Daily
POPS! Diabetes Care Closes $6M in Series A
Nutra Ingredients
Vous Vitamins and Pops combine forces for blood sugar management
FINSMES
POPS! Diabetes Closes $6M Series A Funding
iData Research
POPS! Diabetes Care Announces FDA Clearance of Their POPS!® one System
Silicon Prairie News
Pops on the go virtual care system empowers those with diabetes to Own Their Life®
Innovating with Scott Amyx Show
Interview with Lonny Stormo, CEO of Pops Diabetes Care
Rock Health
Smartphone-connected glucometer POPS! Diabetes Care raised $6M
Drug Delivery Business News
Pops! Diabetes Care launches blood glucose monitoring system
MedWorm
Pops! Diabetes Care launches blood glucose monitoring system
BioSpace
POPS! Diabetes Care Announces the Commercial Launch of their POPS!® one System
NS Medical Devices
FDA approves POPS! one blood glucose monitoring system
Twin Cities Business
Pops! Diabetes Care Raises $1.2M In Latest Funding Round
Twin Cities Pioneer Press
Childrens Hospital Partners With Stillwater Diabetes Care Tech Startup
The Digital Insurer
Zurich Australia partners with Pops Diabetes Care
The Star Tribune
Twin Cities-based Pops! Diabetes Care teams with Children's Minnesota to test diabetes device
The Gazette
Stillwater Startup Works to Improve Diabetes Care
Offering Summary
Company | : | POPS! Diabetes Care, Inc. |
Corporate Address | : | 6770 Stillwater Blvd North, Suite 200, Minneapolis, MN 55082 |
Offering Minimum | : | $9,993.35 |
Offering Maximum | : | $2,558,988.59 |
Minimum Investment Amount(per investor) | : | $200.61 |
Terms
Offering Type | : | Equity |
Security Name | : | Series A-1 Preferred Stock |
Minimum Number of Shares Offered | : | 1,345 |
Maximum Number of Shares Offered | : | 344,413 |
Price per Share | : | $7.43 |
Pre-Money Valuation | : | $17,935,187.84 |
*Maximum number of shares offered subject to adjustment for bonus shares. See bonus info below.
Investment Incentives and Bonuses*
Time-Based Perks:
Super Early Bird: First 7 days
Invest within the first 7 days and receive 15% bonus shares.
Early Bird: Next 7 days
Invest within the next 7 days and receive 10% bonus shares.
Amount-Based Perks:
Tier 1 $1,000+
Invest $1,000 or more and receive 5% bonus shares.
Tier 2 $2,500+
Invest $2,500 or more and receive 10% bonus shares, an invite to Mina’s Studio, and a free 1-month trial access to the Pops Platform (free glucose meter, free 24 glucose tests, access to Mina coaching, access to Pops ecosystem, and $150 exclusive Pops partner discounts).
Tier 3 $5,000+
Invest $5,000 or more and receive 10% bonus shares, an invite to Mina’s Studio, a free 3-month trial access to the Pops Platform (free glucose meter, unlimited glucose testing, access to Mina coaching, access to Pops ecosystem, and $150 exclusive Pops partner discounts), and a quarterly CEO perspective on the business.
Tier 4 $10,000+
Invest $10,000 or more and receive 15% bonus shares, an invite to Mina’s Studio, a free 3-month trial access to the Pops Platform (free glucose meter, unlimited glucose testing, access to Mina coaching, access to Pops ecosystem, and $150 exclusive Pops partner discounts), and a quarterly CEO perspective on the business.
Tier 5 $25,000+
Invest $25,000 or more and receive 20% bonus shares, an invite to Mina’s Studio, a free 3-month trial access to the Pops Platform (free glucose meter, unlimited glucose testing, access to Mina coaching, access to Pops ecosystem, and $150 exclusive Pops partner discounts), a quarterly CEO perspective on the business, and a private call with CEO upon request.
*All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus*
POPS! Diabetic Care, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Series A-1 Preferred Stock at $7.43 / share, you will receive 10 additional shares of Series A-1 Preferred Stock, meaning you'll own 110 shares for $743. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments. Salary payments made to one’s self, a friend or relative.
Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$1,166,946.00
USD
$2,068,597.00
USD
Cash And Cash Equivalents
$249,701.00
USD
$1,426,581.00
USD
Accounts Receivable
$28,080.00
USD
$2,627.00
USD
Short Term Debt
$792,560.00
USD
$446,691.00
USD
Long Term Debt
$2,880,394.00
USD
$1,703,070.00
USD
Revenues And Sales
$163,164.00
USD
$28,684.00
USD
Costs Of Goods Sold
$446,239.00
USD
$23,856.00
USD
Taxes Paid
$0.00
USD
$0.00
USD
Net Income
-$2,427,152.00
USD
-$1,651,287.00
USD
Risks
A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.
Updates
Campaign termination
10 days agoWe want to thank all our investors for the incredible support in our offering! Unfortunately, we have decided to move forward with terminating our offering. Stay tuned for an email from StartEngine which will provide more information on the cancellation and expected refunds if your funds were not previously allocated as investments. Please follow us on LinkedIn https://www.linkedin.com/company/popsdiabetescare/ to stay up to date on all things Pops.
Thanks again! Lonny
Is Pops better than our competition?
27 days agoThis 1-minute video will demonstrate our superior experience. This same experience carries throughout all of our platform:
https://www.youtube.com/shorts/_cTvG_SHHcU
Our campaign ends July 26th. Please invest now and help us change diabetes management for millions of people with diabetes.
20% Revenue increase Q2 2022
28 days agoWe closed our 2nd quarter of 2022 with a 20% increase in revenue and a 56% average quarterly growth in our trailing six quarters of revenue. We are seeing strong uptake of our D2C subscription business, which is a change we made (versus selling devices) for 2022.
Only 12 days left in our StartEngine campaign. We finish up July 26th! One last chance to ask our CEO anything in our July 21 4:00 PM CST live event. Please register before the meeting at this link: https://us02web.zoom.us/webinar/register/WN__72HgnYbRlObrabHoB4F7w
Our Community Joins In! | Insider Investment Notice
about 1 month agoWe're excited to see our community come in and invest in POPS! Diabetes Care, Inc.!
Our Insiders have invested a total of $5,000 into the offering to date!
We hope you join in as well! Invest in POPS!
Please refer to the Company’s offering materials for further information and refer to the Company’s Risk Factors.
Register now for Last Chance Investment webinar
about 1 month agoOur investment opportunity ends in just 18 days! Register now to hear CEO and founder, Lonny Stormo, talk about why investing in Pops now is a great opportunity and where the company is going. You don't want to miss this as you make your final investment decision. Register today for the July 21 at 4:00 CT webinar. You must register to get a link to watch. Register at this link: https://us02web.zoom.us/webinar/register/WN__72HgnYbRlObrabHoB4F7w
Get your Own Your Life t-shirt
about 1 month agoPops is now rewarding people who do their first 10 glucose measurements with Pops with their Own Your Life shirt. This is a great way for to reward people with a shirt they will be proud to wear and generate more public visibility.
Check out this influencer post on Pops Rebel
about 2 months agoWe were surprised and happy to see a post this last week about Pops Rebel from a family of people with diabetes who have 75,000 Instagram and TikTok followers. Pops did not pay for this post, but we love the fun advocacy and visibility. Check out this quick post (which we put on Youtube) for a smile and hear how others see Pops simplicity!
https://youtube.com/shorts/NFM5FDYxif8
Join Facebook Live Event TODAY
about 2 months agoJoin me in a Facebook Live event today at 1:00 PM CST to learn more about Pops in ~15 minutes. Whether for investment or interest in our product for you to own your diabetes, just join at this link:. https://fb.me/e/2GwWJTJIM
Now over $50K!--Learn more at Zoom and Facebook Live Events Coming this Week
about 2 months agoBased on your requests, we are giving you more options to learn about Pops to make your StartEngine investment decision. Please join us for one of these discussions to learn, meet a surprise guest, and get your questions answered.
Facebook Live Event: Scheduled for June 17th at 1:00 PM CST. Just simply click this link to join the event when it starts. https://fb.me/e/2GwWJTJIM
Zoom Event: Scheduled for June 15th at 5:00 PM CST. Register for an invite to this event at this link. Then you will receive a link to add to your calendar to join the event and receive a reminder email before the event starts. https://us02web.zoom.us/webinar/register/WN_FClilBfaR4ufF5fWCTpSeA
Submit your questions now: Just click on this link to submit your questions that our CEO will address in both events.
Signed Another Commercial Agreement
2 months agoMinneapolis, MN 09 June 2022: Pops is proud to announce signing a commercial agreement with The Children's Mercy Hospital of Kansas City to provide the Pops solution for children with diabetes. "Our initial clinical study, which showed positive A1c improvement, was done with pediatric patients through Children's Minnesota hospital, and we are now excited to provide commercially the Pops product to another set of people working to manage their diabetes", said Lonny Stormo, CEO of Pops.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}